Savior Lifetec Corporation (4167.TWO) Stock
Savior Lifetec Corporation engages in the research, development, design, manufacture, and sale of carbapenem generics in the Americas, Asia, Taiwan, Europe, and internationally. The company offers injection generics, controlled-release generics, the development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
About Savior Lifetec Corporation
Savior Lifetec Corporation engages in the research, development, design, manufacture, and sale of carbapenem generics in the Americas, Asia, Taiwan, Europe, and internationally. The company offers injection generics, controlled-release generics, the development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms. It also provides medicine manufacturer technology and services. In addition, the company sells antibacterial raw materials and injectables. Savior Lifetec Corporation was founded in 1993 and is headquartered in Tainan City, Taiwan.
Savior Lifetec Corporation (4167.TWO) stock trades at $21.00 with a market capitalization of $6.96B. The stock is valued at a price-to-earnings (P/E) ratio of 7.14, price-to-book of 1.58, price-to-sales of 6.21. Over the past 52 weeks the stock has ranged between $15.64 and $23.95, and currently trades 12.3% below its 52-week high. It pays a dividend yielding 3.90%.
On profitability, Savior Lifetec Corporation generates a return on equity (ROE) of 25.70%, above the typical market range of roughly 12-15%, an operating margin of 5.53%, a net profit margin of 91.92%.
Official website: www.saviorlifetec.com.tw
Savior Lifetec Corporation (4167.TWO) — frequently asked questions
What is Savior Lifetec Corporation (4167.TWO) stock price today?
Savior Lifetec Corporation (4167.TWO) is currently trading at $21.00, up 1.2% today.
What is 4167.TWO P/E ratio?
Savior Lifetec Corporation's P/E ratio is 7.14. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 4167.TWO return on equity (ROE)?
Savior Lifetec Corporation's return on equity (ROE) is 25.70%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.
What is Savior Lifetec Corporation's market cap?
Savior Lifetec Corporation has a market capitalization of $6.96B.
Does 4167.TWO pay a dividend?
Yes. Savior Lifetec Corporation currently yields 3.90%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 4167.TWO carry?
Savior Lifetec Corporation has a debt-to-equity ratio of 0.07. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 4167.TWO's profit margin?
Savior Lifetec Corporation reports a net profit margin of 91.92% — the share of revenue left after every cost, including tax and interest.
What sector is 4167.TWO in?
Savior Lifetec Corporation is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 4167.TWO listed on?
Savior Lifetec Corporation trades on TWO under the ticker 4167.TWO.
What is 4167.TWO's 52-week range?
Over the last year Savior Lifetec Corporation has traded between $15.64 and $23.95.
Related Healthcare Stocks
Popular Stocks
Screens 4167.TWO currently matches
On the figures above, Savior Lifetec Corporation passes the filters for 22 of our ready-made screens, among them Undervalued Stocks, Low PE Stocks, Cheap Stocks To Buy Now. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.